[go: up one dir, main page]

NO20055390D0 - Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer - Google Patents

Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer

Info

Publication number
NO20055390D0
NO20055390D0 NO20055390A NO20055390A NO20055390D0 NO 20055390 D0 NO20055390 D0 NO 20055390D0 NO 20055390 A NO20055390 A NO 20055390A NO 20055390 A NO20055390 A NO 20055390A NO 20055390 D0 NO20055390 D0 NO 20055390D0
Authority
NO
Norway
Prior art keywords
thorium
radiotherapy
soft tissue
tissue diseases
diseases
Prior art date
Application number
NO20055390A
Other languages
English (en)
Other versions
NO332931B1 (no
NO20055390L (no
Inventor
Roy Larsen
Oyvind Bruland
Original Assignee
Algeta As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0308731.9A external-priority patent/GB0308731D0/en
Application filed by Algeta As filed Critical Algeta As
Publication of NO20055390D0 publication Critical patent/NO20055390D0/no
Publication of NO20055390L publication Critical patent/NO20055390L/no
Publication of NO332931B1 publication Critical patent/NO332931B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO20055390A 2003-04-15 2005-11-15 Anvendelse av kompleks av thorium-227 og komplekseringsmiddel i fremstilling av et medikament, farmasoytisk sammensetning omfattende mykvevsmalrettingskompleks, mykvevsmalrettingskompleks, fremgangsmate for a danne et kompleks samt sett for bruk i anvendelsen. NO332931B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0308731.9A GB0308731D0 (en) 2003-04-15 2003-04-15 Method of radiotherapy
PCT/GB2004/001654 WO2004091668A1 (en) 2003-04-15 2004-04-15 Thorium-227 for use in radiotherapy of soft tissue disease

Publications (3)

Publication Number Publication Date
NO20055390D0 true NO20055390D0 (no) 2005-11-15
NO20055390L NO20055390L (no) 2006-01-16
NO332931B1 NO332931B1 (no) 2013-02-04

Family

ID=35385222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055390A NO332931B1 (no) 2003-04-15 2005-11-15 Anvendelse av kompleks av thorium-227 og komplekseringsmiddel i fremstilling av et medikament, farmasoytisk sammensetning omfattende mykvevsmalrettingskompleks, mykvevsmalrettingskompleks, fremgangsmate for a danne et kompleks samt sett for bruk i anvendelsen.

Country Status (18)

Country Link
EP (1) EP1617876B1 (no)
JP (2) JP5006032B2 (no)
KR (2) KR20060015507A (no)
CN (1) CN100586484C (no)
AU (1) AU2004229218B2 (no)
BR (1) BRPI0409387B8 (no)
CA (1) CA2522148C (no)
CY (1) CY1115407T1 (no)
DK (1) DK1617876T3 (no)
EA (1) EA008195B1 (no)
ES (1) ES2486845T3 (no)
IL (1) IL171148A (no)
MX (1) MXPA05010804A (no)
NO (1) NO332931B1 (no)
NZ (3) NZ606996A (no)
PL (1) PL1617876T3 (no)
PT (1) PT1617876E (no)
ZA (1) ZA200507983B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1617876B1 (en) * 2003-04-15 2014-05-14 Algeta AS Thorium-227 for use in radiotherapy of soft tissue disease
GB201002508D0 (en) * 2010-02-12 2010-03-31 Algeta As Product
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201105298D0 (en) * 2011-03-29 2011-05-11 Algeta Asa Pharmaceutical preparation
GB201600154D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
EP3554257B1 (en) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Compositions and methods that modulate white blood cells or neutrophils in a companion animal
FR3088769B1 (fr) * 2018-11-15 2020-12-25 Orano Med Procede de preparation d'au moins un generateur a haute teneur en radium-228
RU2767567C1 (ru) * 2020-10-27 2022-03-17 Станислав Анатольевич Дороватовский Комплексные соединения, содержащие в своем составе радионуклид 227Th, а также бисфосфонатный фрагмент, способы их получения, а также потенциальное применение в качестве действующего вещества в составе остеотропного радиофармацевтического лекарственного препарата
CN119912489B (zh) * 2024-12-23 2026-02-03 中国科学院近代物理研究所 一种膦酸钍框架材料及其制备方法和在钍镭发生器中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2034484C (en) * 1989-06-19 2000-08-15 Maurits W. Geerlings Radioimmunotherapy using .alpha.-particles emission
JPH07505886A (ja) * 1992-04-13 1995-06-29 ザ　ダウ　ケミカル　カンパニー マクロ環状キレート化剤の製造方法及びキレートの形成並びにその結合体
CN1073860C (zh) * 1998-08-20 2001-10-31 中国核动力研究设计院 用于骨肿瘤治疗或诊断的放射性药物药盒的制备方法
MY133346A (en) * 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
HUP0203743A2 (en) * 2000-02-25 2003-02-28 R Keith Frank Actinium-225 complexes and conjugates for radioimmunotherapy
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
EP1617876B1 (en) * 2003-04-15 2014-05-14 Algeta AS Thorium-227 for use in radiotherapy of soft tissue disease

Also Published As

Publication number Publication date
JP2006523664A (ja) 2006-10-19
DK1617876T3 (da) 2014-07-21
KR20060015507A (ko) 2006-02-17
BRPI0409387B8 (pt) 2021-05-25
AU2004229218A1 (en) 2004-10-28
PT1617876E (pt) 2014-08-04
EA200501456A1 (ru) 2006-06-30
BRPI0409387B1 (pt) 2021-05-11
CA2522148C (en) 2010-07-13
CY1115407T1 (el) 2017-01-04
BRPI0409387A (pt) 2006-04-18
NZ595758A (en) 2013-02-22
EP1617876A1 (en) 2006-01-25
NZ606996A (en) 2014-08-29
NO332931B1 (no) 2013-02-04
CN1805760A (zh) 2006-07-19
KR101274867B1 (ko) 2013-06-13
KR20110022743A (ko) 2011-03-07
ES2486845T3 (es) 2014-08-19
PL1617876T3 (pl) 2015-03-31
ZA200507983B (en) 2007-03-28
HK1094150A1 (zh) 2007-03-23
CA2522148A1 (en) 2004-10-28
JP5006032B2 (ja) 2012-08-22
MXPA05010804A (es) 2006-03-09
EP1617876B1 (en) 2014-05-14
JP5468597B2 (ja) 2014-04-09
IL171148A (en) 2013-12-31
JP2012051942A (ja) 2012-03-15
NO20055390L (no) 2006-01-16
NZ543044A (en) 2010-04-30
AU2004229218B2 (en) 2009-05-07
EA008195B1 (ru) 2007-04-27
CN100586484C (zh) 2010-02-03

Similar Documents

Publication Publication Date Title
NO20034465D0 (no) Medisinsk pasientsimulator
DE502005007353D1 (de) Zervikale zwischenwirbelprothese
EP1731113A4 (en) MEDICAL TREATMENT KIT
PT1506781E (pt) Composicao para tratamento vaginal
DE60315135D1 (de) Therapiesonde
ATE402167T1 (de) 4-tetrazolyl-4-phenylpiperidinderivate zur schmerzbehandlung
ITPD20040252A1 (it) Irrigatore chirurgico
EP1570270A4 (en) THERAPEUTIC BIOKON JUGATE
DK1597171T3 (da) Terapeutisk mikroskum
DE602004016877D1 (de) Untersuchungsstuhl
NO20055390D0 (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
ATA13602003A (de) Therapeutisches behandlungsgerät
EP1781685A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS
DK1553950T3 (da) Terapeutisk behandling
NO20050689L (no) Terapeutisk anvendelse
DE60321507D1 (de) Katheter zur künstlichen Befruchtung
DE60312992D1 (de) Medizinisches implantat
NO20022747L (no) Behandlingsstol
FI20051218L (fi) Keinotekoinen harjoituslyöntialue ympärivuotiseen käyttöön
NO20030716D0 (no) Stimulator for vagina
EP1944041A4 (en) THERAPEUTIC AGENT AGAINST NEUROGENIC PAIN
DE10394304D2 (de) Katheterfixierung
SE0400718D0 (sv) Therapeutic agents
SE0403119D0 (sv) Therapeutic agents
DE602005018632D1 (de) En patientenstuhl